Hemispherx BioPharma, Inc Stock Nyse
Equities
US42366C3016
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 2.57M | Capitalization | 20.96M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -28M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 8.16 x |
P/E ratio 2024 * |
-0.78
x | P/E ratio 2025 * |
-0.89
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.01% |
Latest transcript on Hemispherx BioPharma, Inc
Managers | Title | Age | Since |
---|---|---|---|
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
Robert Dickey
DFI | Director of Finance/CFO | 68 | 22-04-03 |
Chief Tech/Sci/R&D Officer | - | 22-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nancy K. Bryan
BRD | Director/Board Member | 66 | 23-03-27 |
William Mitchell
CHM | Chairman | 89 | 98-06-30 |
Thomas Equels
CEO | Chief Executive Officer | 71 | 08-11-16 |
1st Jan change | Capi. | |
---|---|---|
-0.18% | 103B | |
+3.23% | 96.73B | |
+1.66% | 21.31B | |
-15.70% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.02% | 13.68B | |
+6.17% | 13.44B | |
+23.92% | 10.98B |